Guanidine

Guanidine

SCHEMBL8691609

CN1c2ccccc2C[C@H]1C(=O)O.Cl.N=C(N)N

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2

The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACE P12821 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanidine SCHEMBL8690711 1.00 ACE (0.47) ACE
SCHEMBL5847071 0.91 ACE (0.54) ACE
SCHEMBL4278365 0.91 ACE (0.54) ACE
SCHEMBL5847068 0.91 ACE (0.54) ACE
SCHEMBL12626587 0.83 XIAP (0.47) ACE
Hydrochloric Acid SCHEMBL27419433 0.82 XIAP (0.38)
Guanidine SCHEMBL8690427 0.81 NOTUM (0.39)
Hydrochloric Acid SCHEMBL8690716 0.81 XIAP (0.38)
Hydrochloric Acid SCHEMBL8691613 0.81 XIAP (0.38)
SCHEMBL3365538 0.79 NOTUM (0.49) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5852046-A Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1998-12-22 US disclosed